MedPath

Investigating the effect of Eye Movement Desensitization and Reprocessing (EMDR) on fibromyalgia: a ten times replicated multiple-baseline experimental case study

Completed
Conditions
chronic pain syndrome
Fibromyalgia
10023213
10077546
Registration Number
NL-OMON50804
Lead Sponsor
GGZ Noord-Holland-Noord
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

1) a medical diagnosis of fibromyalgia
2) age of 18 years and older
3) an average pain intensity score in the past week of >= 7 on a Numerical
Rating Scale for Pain
4) sufficient understanding of the Dutch language verbally and in writing, in
order to be able to participate
5) willingness to participate in the study (as indicated by the signed informed
consent)

Exclusion Criteria

1) an acute condition of psychosis or bipolar disorder
2) an acute suicidal risk
3) an IQ < 80
4) substance dependency
5) stable on use of medication. Medication was not started less than 3 months
ago (e.g. psychotropic drugs, analgetics or other medication with effect on
pain or symptoms of fibromyalgia). If medication was started more than 3 months
ago, medication can be continued. We will ask patients to keep their medication
prescriptions as stable as possible during the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Daily data are collected of the primary parameter which is pain intensity. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary parameters are stiffness in muscles and joints, fatigue, the impact<br /><br>of pain on daily life, the impact of pain on sleep and a selection of four PTSD<br /><br>symptoms.<br /><br><br /><br>Exploratory analysis:<br /><br>At specific time points data will be collected of the impact of FM complaints<br /><br>on daily life, PTSD symptoms, psychiatric symptoms and functioning in general,<br /><br>depressive symptoms, central sensitization symptoms and the patient impression<br /><br>of change. The time points are at the start of the baseline, at the end of the<br /><br>baseline period which corresponds to the start of the intervention, directly<br /><br>after the EMDR treatment, one month after the EMDR treatment and three months<br /><br>after the EMDR treatment.</p><br>
© Copyright 2025. All Rights Reserved by MedPath